Concepedia

Karin Briner

KB

29

Publications

1.2K

Citations

19

H-Index

1987

Active since

Affiliations

Eli Lilly (United States)(Current)

Broad Institute

Harvard University

University of Zurich

Novartis (Switzerland)

Karin Briner is an author at Eli Lilly (United States) specializing in medicine, natural sciences, and pharmacology.

Top concepts

Publications per year

1987–2023

29

Publications

29

Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy

Simone Bonazzi, Eva d’Hennezel, Rohan E. J. Beckwith et al. · Cell chemical biology · 2023 · 135 citations · Full text

Discovery of Small Molecule Splicing Modulators of Survival Motor Neuron-2 (SMN2) for the Treatment of Spinal Muscular Atrophy (SMA)

Atwood K. Cheung, Brian Hurley, Ryan Kerrigan et al. · Journal of Medicinal Chemistry · 2018 · 128 citations · Full text

, , +16

Glycosylidene Carbenes a new approach to glycoside synthesis. Part 1. Preparation of glycosylidene‐derived diaziridines and diazirines

Karin Briner, Andrea Vasella · Helvetica Chimica Acta · 1989 · 103 citations

, , +14

Water-Compatible Cycloadditions of Oligonucleotide-Conjugated Strained Allenes for DNA-Encoded Library Synthesis

Matthias V. Westphal, Liam Hudson, Jeremy W. Mason et al. · Journal of the American Chemical Society · 2020 · 86 citations · Full text

, , +17

DNA-encoded library-enabled discovery of proximity-inducing small molecules

Jeremy W. Mason, Yuen Ting Chow, Liam Hudson et al. · Nature Chemical Biology · 2023 · 76 citations · Full text

, , +8

Rows per page

1–5 of 29